NeuroPace nabs first FDA approval for responsive neurostimulation
This article was originally published in Clinica
Executive Summary
NeuroPace’s RNS system has become the first closed-loop responsive neurostimulation device to gain US FDA premarket approval. The technology is approved for use on patients with drug-resistant epilepsy.